The Science of Growth Hormone Decline Human growth hormone production peaks during adolescence and young adulthood, then progressively declines at an estimated rate of 14% per decade (1)
Reporting social media-based adverse events with artificial intelligence: elaborating the challenges -mitigating with innovation
The trial followed more than 300 participants for up to 64 weeks, and Whartons team saw, on average, a nearly 14 percent drop in body weight among people taking the drug
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for T2DM, exert both metabolic and anti-inflammatory effects, which may offer therapeutic benefits for psoriatic disease, particularly in the early stages of PsA
Clinical data from the SURMOUNT trials demonstrated that tirzepatide delivers weight reductions between 20-21% at the highest therapeutic dose, significantly outperforming older GLP-1-only treatments
Ehud Ur, an endocrinologist in Vancouver, said being able to prescribe generic semaglutide will be "very exciting," noting that semaglutide would be an effective medication for many of his patients, but they aren't on it because they can't afford it